mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.2 |
mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.2 |
mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
CAY10618 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |